Forty-seven clinically stable kidney transplant recipients were vaccinated once with Prevenar and HLA class I and II and MICA antibodies were analyzed by LuminexTM technology (LABScreenTM Mixed Beads) prior to vaccination and at month 1 and month 12 thereafter. This evidence concerns the gene MICA and medical procedure.